Wikidata

(Q53860535)

English

STRIDE 1: effects of the selective ET(A) receptor antagonist, sitaxsentan sodium, in a patient population with pulmonary arterial hypertension that meets traditional inclusion criteria of previous pulmonary arterial hypertension trials.

scientific article

In more languages

Statements

title
STRIDE 1: effects of the selective ET(A) receptor antagonist, sitaxsentan sodium, in a patient population with pulmonary arterial hypertension that meets traditional inclusion criteria of previous pulmonary arterial hypertension trials. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
15838366
retrieved
21 May 2018
reference URL
http://europepmc.org/abstract/MED/15838366

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53860535&oldid=1153939397"